The publisher's Medical Devices sector report, “Hydrogels Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Hydrogels pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Hydrogels includes dressings that consist of 96% water with a matrix of insoluble polymers embedded in it.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Hydrogels includes dressings that consist of 96% water with a matrix of insoluble polymers embedded in it.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hydrogels under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hydrogels and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Hydrogels under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Hydrogels - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3QMatrix, Inc. (Inactive)
- Abeona Therapeutics Inc
- AgeX Therapeutics Inc
- Alafair Biosciences Inc
- Albert Ludwigs University of Freiburg
- Amend Surgical, Inc.
- Angiotech Pharmaceuticals Inc
- BioCure Inc
- Biomendics LLC
- Brigham and Women's Hospital
- CelaCare Technologies LLC
- Ceramicos Para Aplicacoes Medicas SA
- Chi2Gel Ltd.
- CorMedix Inc
- Drexel University
- Edixomed Ltd
- Exogenus Therapeutics SA
- Flexion Therapeutics Inc
- Gel4Med Inc
- Gelesis Inc
- GelSana Therapeutics Inc
- HyperBranch Medical Technology Inc
- Icahn School of Medicine at Mount Sinai
- In2cure AB
- Institute of Nano Science and Technology
- Ionic Pharmaceuticals LLC
- IPI Singapore
- Jenarron Therapeutics Ltd
- Johns Hopkins University
- Kane Biotech Inc
- Keratin Biosciences Inc
- Magle Chemoswed AB
- Neotherix Ltd
- Northwestern University
- Novyx Technologies LLC
- O2 Regentech LLC
- Ohio State University
- Orla Protein Technologies Ltd
- Piramal Enterprises Ltd
- Plurogen Therapeutics Inc
- Queensland University of Technology
- Quick-Med Technologies Inc
- Regentys Corp
- Scarless Laboratories Inc
- Smith & Nephew Plc
- SolasCure Ltd
- Sonoma Pharmaceuticals Inc
- Spanish National Research Council
- Squid Healthcare Inc
- Stanford University
- SynDermix AG
- Syracuse Biolabs Inc
- Syracuse University
- Tectum
- Tel Aviv Sourasky Medical Center
- Tel Aviv University
- Texas Medical Center
- Tokyo University of Science
- University of California San Diego
- University of Florida
- University of Illinois at Chicago
- University of Queensland
- University of Wisconsin Madison
- Ventrix Inc
- VTT Technical Research Centre of Finland Ltd
- Washington University in St Louis
- Zeomedix, LLC